Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

7

Revenue 2017

GlaxoSmithKline

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of GlaxoSmithKline's 2013 sales performance.

GlaxoSmithKline

Shionogi scores FDA approval for new cUTI antibiotic

Shionogi scores FDA approval for new cUTI antibiotic

Also looking to bring a new antibiotic to market is  GlaxoSmithKline, which recently initiated two phase 3 trials of its new-class candidate.

Targacept picks Solvay's Stephen Hill to fill vacant CEO post

Targacept picks Solvay's Stephen Hill to fill vacant CEO post As Targacept's president and CEO, Hill will need to refocus the firm following the termination last year of its partnership with GlaxoSmithKline – with the loss of a potential $1.5bn

Merck acquires pre-clinical biotech Calporta for up to $576m

Merck acquires pre-clinical biotech Calporta for up to $576m Calporta was one of eight San Diego-based biotechs created as part of a deal between venture capital firm Avalon Ventures and pharma giant GlaxoSmithKline.

Nucala works in rare inflammatory disease, says GSK

Nucala works in rare inflammatory disease, says GSK GlaxoSmithKline is eyeing another regulatory filing for its IL-5 inhibitor Nucala, after reporting positive phase 3 results with the drug in rare disease hypereosinophilic syndrome (HES).

The long and winding road to asthma breakthroughs

The long and winding road to asthma breakthroughs Respiratory biologics are booming thanks to scientists who refused to be derailed by early research setbacks

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

R&D protocol amendments
Rethinking trials: the pros and cons of protocol amendments
Protocol amendments occur often and can be beneficial, but the steps involved can be complex...
Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...

Infographics